Lourie, Circuit Judge.
Teva Pharmaceuticals International GmbH ("Teva") appeals from a combined final written decision of the U.S. Patent and Trademark Office ("PTO") Patent Trial and Appeal Board ("Board") holding that the claims of U.S. Patents 9,340,614 ("'614 patent"), 9,266,951 ("'951 patent"), and 9,890,210 ("'210 patent") are unpatentable...
Let's get started

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.
- Updated daily.
- Uncompromising quality.
- Complete, Accurate, Current.